LISBON — The diabetes and weight-loss drug semaglutide improves heart failure–related symptoms and physical limitations regardless of diuretic use in patients with obesity-related heart failure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback